Network meta-analysis of first-line R-CHOP-based regimens in MYC/BCL2 double-expressor diffuse large B-cell lymphoma.

Epidaza (chidamide) - Chipscreen

Rituxan (rituximab) - Roche

bortezomib - Generic mfg.

Polivy (polatuzumab vedotin-piiq) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42416051

Baoping Guo; Chengcheng Liao; Hao Cheng; Hong Cen; Jie Sun; Lin Zeng; Qing Ke; Xiaohong Tan; Xuanzhang Li

Jul 9, 2026